Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ CD22L-N3 (BPC-Sia-LacNAc-N3)
SDP

Catalog No. 88301 Shop All Novus Products
Change view
Click to view available options
Quantity:
1 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
88-301 1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. 88-301 Supplier R&D Systems™ Supplier No. 8830/1

Customers require a valid business account associated to their profile to access pricing and ordering options.

missing translation for 'validMainframeMsg'

This item is not returnable. View return policy

A Tocris product, part of R&D Systems. CD22 ligand with azide group for onward chemistry

CD22L-N3 (BPC-Sia-LacNAc-N3) is a functionalized CD22 receptor ligand for trogocytosis targeting chimera (TrogoTAC) research and development. CD22 targeted TrogoTACs are bispecific molecules capable of inducing protein transfer from the target cell to B cells, by redirecting trogocytosis. Comprises an azide functionalized CD22 ligand for conjugation.

Specifications

Chemical Name or Material (2R,4S,5R,6R)-6-((1R,2R)-3-([1,1'-Biphenyl]-4-carboxamido)-1,2-dihydroxypropyl)-5-acetamido-2-(((2R,3R,4S,5R,6S)-6-(((2R,3S,4R,5R,6R)-5-acetamido-6-(2-azidoethoxy)-4-hydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H
CAS 1019642-47-7
Quantity 1 mg
Product Line Tocris
Target Glycobiology Probes
Molecular Formula C40H54N6O19
Purity 95%
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.